Approved by the FDA and certified with a CE mark for both 2D and 3D mammography.
The highest number of independent, peer-reviewed studies in breast AI.
Take advantage of their constantly improving deep learning algorithm.
Mammography is a reliable screening method, but it does have its challenges. Factors such as limited radiologist capacity, dense breast tissue, and changing demographics can make these challenges more pronounced. Transpara provides radiologists with solutions to overcome them.
No matter the acquisition method (FFDM or DBT) or the reading setup (single or double reading).
Especially in dense breast tissue, Transpara performs exceptionally well in the most challenging cases, benefiting the half of women with denser breast tissue.
Provides both a reliable risk snapshot and the ability to monitor risk over time, identifying warning signs in personal trends.
